Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Universal Health Services Inc ha un obiettivo di prezzo di consenso pari a $204.92, stabilito in base alle ultime valutazioni degli analisti di 28. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Cantor Fitzgerald y Barclays il octubre 7, 2025, octubre 7, 2025 y septiembre 18, 2025. Con un obiettivo di prezzo medio di $242 tra le Wells Fargo, Cantor Fitzgerald y Barclays, c'è un implicito 23.40% upside per Universal Health Services Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/07/2025 | 26.97% | Wells Fargo | $210 → $249 | Maintains | Overweight | |||
10/07/2025 | 15.75% | Cantor Fitzgerald | $227 → $227 | Reiterates | Neutral → Neutral | |||
09/18/2025 | 27.48% | Barclays | $259 → $250 | Maintains | Overweight | |||
08/26/2025 | 15.75% | Cantor Fitzgerald | $227 → $227 | Reiterates | Neutral → Neutral | |||
08/19/2025 | 5.04% | RBC Capital | $201 → $206 | Maintains | Sector Perform | |||
08/14/2025 | 3.51% | Baird | $243 → $203 | Maintains | Neutral | |||
08/14/2025 | 7.08% | Wells Fargo | $225 → $210 | Maintains | Overweight | |||
08/04/2025 | -0.57% | JP Morgan | $215 → $195 | Maintains | Neutral | |||
07/30/2025 | 32.07% | Barclays | $257 → $259 | Maintains | Overweight | |||
07/16/2025 | -5.67% | B of A Securities | $215 → $185 | Downgrade | Neutral → Underperform | |||
04/30/2025 | 2.49% | RBC Capital | $211 → $201 | Maintains | Sector Perform | |||
04/29/2025 | 31.05% | Barclays | $249 → $257 | Maintains | Overweight | |||
04/15/2025 | 14.22% | Baird | $274 → $224 | Downgrade | Outperform → Neutral | |||
04/09/2025 | 6.06% | Guggenheim | → $208 | Initiates | → Buy | |||
03/26/2025 | 1.98% | Morgan Stanley | → $200 | Initiates | → Equal-Weight | |||
03/10/2025 | 14.73% | Wells Fargo | $230 → $225 | Maintains | Overweight | |||
02/28/2025 | 13.71% | Stephens & Co. | $210 → $223 | Maintains | Equal-Weight | |||
02/27/2025 | 7.08% | Stephens & Co. | $210 → $210 | Reiterates | Equal-Weight → Equal-Weight | |||
02/27/2025 | 26.97% | Barclays | $271 → $249 | Maintains | Overweight | |||
12/17/2024 | 15.24% | JP Morgan | → $226 | Assumes | → Neutral | |||
11/26/2024 | 27.99% | TD Cowen | $275 → $251 | Maintains | Buy | |||
11/25/2024 | 17.28% | Wells Fargo | $285 → $230 | Maintains | Overweight | |||
11/06/2024 | 45.33% | Wells Fargo | $275 → $285 | Maintains | Overweight | |||
10/28/2024 | 40.23% | TD Cowen | $283 → $275 | Maintains | Buy | |||
10/28/2024 | 7.59% | RBC Capital | $222 → $211 | Maintains | Sector Perform | |||
10/25/2024 | 38.19% | Barclays | $256 → $271 | Maintains | Overweight | |||
10/25/2024 | 11.67% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
10/22/2024 | 40.23% | Wells Fargo | $255 → $275 | Maintains | Overweight | |||
10/16/2024 | 44.31% | TD Cowen | $220 → $283 | Upgrade | Hold → Buy | |||
10/11/2024 | — | Keybanc | — | Initiates | → Sector Weight | |||
10/04/2024 | 11.67% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
10/01/2024 | 11.67% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
09/09/2024 | 13.2% | RBC Capital | $189 → $222 | Maintains | Sector Perform | |||
09/04/2024 | 39.72% | Baird | $236 → $274 | Maintains | Outperform | |||
08/20/2024 | 11.67% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
08/19/2024 | 11.67% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
08/14/2024 | 36.15% | UBS | $247 → $267 | Maintains | Buy | |||
07/30/2024 | 16.77% | Goldman Sachs | $200 → $229 | Maintains | Buy | |||
07/30/2024 | 30.03% | Wells Fargo | $200 → $255 | Maintains | Overweight | |||
07/26/2024 | 12.18% | TD Cowen | $183 → $220 | Maintains | Hold | |||
07/26/2024 | 11.67% | Cantor Fitzgerald | $162 → $219 | Upgrade | Underweight → Neutral | |||
07/26/2024 | 30.54% | Barclays | $198 → $256 | Upgrade | Equal-Weight → Overweight | |||
07/25/2024 | 1.98% | Stephens & Co. | $200 → $200 | Reiterates | Equal-Weight → Equal-Weight | |||
07/25/2024 | -17.39% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
07/10/2024 | 0.96% | Barclays | $189 → $198 | Maintains | Equal-Weight | |||
07/10/2024 | -17.39% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
07/09/2024 | -17.39% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
07/02/2024 | -17.39% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
06/26/2024 | 20.34% | Baird | $198 → $236 | Upgrade | Neutral → Outperform | |||
05/30/2024 | -5.16% | JP Morgan | $182 → $186 | Maintains | Neutral | |||
05/30/2024 | 0.96% | Baird | → $198 | Initiates | → Neutral | |||
05/20/2024 | 15.24% | UBS | $189 → $226 | Upgrade | Neutral → Buy | |||
05/07/2024 | -3.63% | RBC Capital | $183 → $189 | Maintains | Sector Perform | |||
04/30/2024 | -6.69% | TD Cowen | $181 → $183 | Maintains | Hold | |||
04/26/2024 | -3.63% | Barclays | $181 → $189 | Maintains | Equal-Weight | |||
04/25/2024 | -5.67% | Stephens & Co. | $185 → $185 | Reiterates | Equal-Weight → Equal-Weight | |||
04/12/2024 | 3.51% | Deutsche Bank | $208 → $203 | Maintains | Buy | |||
04/10/2024 | -20.45% | Cantor Fitzgerald | $156 → $156 | Reiterates | Underweight → Underweight | |||
03/28/2024 | 1.98% | Wells Fargo | $195 → $200 | Maintains | Overweight | |||
03/13/2024 | -7.19% | JP Morgan | $144 → $182 | Maintains | Neutral | |||
03/12/2024 | -6.69% | RBC Capital | $161 → $183 | Maintains | Sector Perform | |||
03/06/2024 | 1.98% | Mizuho | $175 → $200 | Maintains | Buy | |||
03/06/2024 | -7.7% | Barclays | → $181 | Initiates | → Equal-Weight | |||
03/05/2024 | -20.45% | Cantor Fitzgerald | $156 → $156 | Reiterates | Underweight → Underweight | |||
03/04/2024 | -3.63% | Goldman Sachs | $170 → $189 | Maintains | Buy | |||
03/01/2024 | -7.7% | TD Cowen | $140 → $181 | Maintains | Market Perform | |||
02/29/2024 | -20.45% | Cantor Fitzgerald | $148 → $156 | Maintains | Underweight | |||
02/29/2024 | -1.59% | Citigroup | $170 → $193 | Maintains | Buy | |||
02/29/2024 | -9.74% | UBS | $152 → $177 | Maintains | Neutral | |||
01/02/2024 | -9.74% | Wells Fargo | → $177 | Upgrade | Equal-Weight → Overweight | |||
12/11/2023 | — | Goldman Sachs | — | Upgrade | Sell → Buy | |||
11/17/2023 | -26.57% | JP Morgan | $152 → $144 | Maintains | Neutral | |||
10/20/2023 | -29.12% | Wells Fargo | $153 → $139 | Maintains | Equal-Weight | |||
09/21/2023 | -27.59% | Barclays | $142 → $142 | Maintains | Equal-Weight | |||
09/14/2023 | -24.53% | Cantor Fitzgerald | → $148 | Reiterates | Underweight → Underweight | |||
07/27/2023 | -6.69% | B of A Securities | → $183 | Maintains | Buy | |||
07/27/2023 | -21.98% | Wells Fargo | → $153 | Maintains | Equal-Weight | |||
07/27/2023 | -13.82% | Credit Suisse | $163 → $169 | Maintains | Outperform | |||
07/26/2023 | -20.96% | Stephens & Co. | → $155 | Reiterates | Equal-Weight → Equal-Weight | |||
07/11/2023 | -13.31% | Mizuho | $150 → $170 | Maintains | Buy | |||
06/02/2023 | -16.88% | B of A Securities | → $163 | Assumes | Neutral → Buy | |||
05/26/2023 | — | SVB Securities | — | Upgrade | Market Perform → Outperform | |||
05/16/2023 | -29.12% | Goldman Sachs | $124 → $139 | Maintains | Sell | |||
05/16/2023 | -23.51% | Mizuho | $140 → $150 | Maintains | Buy | |||
05/08/2023 | -21.47% | TD Cowen | $138 → $154 | Maintains | Market Perform | |||
04/27/2023 | -15.86% | Citigroup | $150 → $165 | Maintains | Buy | |||
04/27/2023 | -26.06% | Stephens & Co. | $140 → $145 | Maintains | Equal-Weight | |||
04/27/2023 | -20.96% | Deutsche Bank | $145 → $155 | Maintains | Buy | |||
04/27/2023 | -22.49% | RBC Capital | $130 → $152 | Maintains | Sector Perform | |||
04/27/2023 | -16.88% | Credit Suisse | $153 → $163 | Maintains | Outperform | |||
04/25/2023 | -27.59% | Barclays | $132 → $142 | Upgrade | Underweight → Equal-Weight | |||
04/21/2023 | -27.08% | Cantor Fitzgerald | → $143 | Initiates | → Underweight | |||
04/19/2023 | -20.96% | UBS | $167 → $155 | Maintains | Neutral | |||
04/19/2023 | -32.18% | JP Morgan | → $133 | Initiates | → Neutral | |||
03/06/2023 | -26.06% | Deutsche Bank | $168 → $145 | Maintains | Buy | |||
03/06/2023 | -28.61% | Mizuho | $144 → $140 | Maintains | Buy | |||
03/06/2023 | -29.63% | Wells Fargo | $154 → $138 | Maintains | Equal-Weight | |||
03/03/2023 | -21.98% | Credit Suisse | $157 → $153 | Maintains | Outperform | |||
03/01/2023 | -33.71% | RBC Capital | $114 → $130 | Maintains | Sector Perform | |||
03/01/2023 | -28.61% | Stephens & Co. | $155 → $140 | Maintains | Equal-Weight |
El último precio objetivo de Universal Health Services (NYSE:UHS) fue comunicado por Wells Fargo el octubre 7, 2025. La firma de analistas fijó un precio objetivo para $249.00 que espera UHS a rise dentro de 12 meses (un posible 26.97% upside). 29 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Universal Health Services (NYSE:UHS) fue proporcionada por Wells Fargo, y Universal Health Services mantuvo su overweight calificación.
La última revisión al alza de Universal Health Services Inc se produjo en octubre 16, 2024, cuando TD Cowen elevó su precio objetivo a $283. TD Cowen anteriormente tenía a hold para Universal Health Services Inc.
La última revisión a la baja de Universal Health Services Inc se produjo en julio 16, 2025, cuando B of A Securities cambió su precio objetivo de $215 a $185 para Universal Health Services Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Universal Health Services, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Universal Health Services se registró el octubre 7, 2025, por lo que la próxima calificación estará disponible en torno al octubre 7, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Universal Health Services (UHS) fue un mantuvo con un precio objetivo de $210.00 a $249.00. El precio actual al que cotiza Universal Health Services (UHS) es de $196.11, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.